|
Volumn 12, Issue 4, 2003, Pages 493-502
|
Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 15-3 ANTIGEN;
CANCER VACCINE;
MONOCLONAL ANTIBODY;
PEPTIDE;
RECOMBINANT PROTEIN;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CELL MEMBRANE;
CHEMISTRY;
CYTOLOGY;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
DOSE RESPONSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
KINETICS;
LUNG TUMOR;
LYMPHOCYTE;
MALE;
METABOLISM;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
TIME;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
CA-15-3 ANTIGEN;
CANCER VACCINES;
CELL MEMBRANE;
DENDRITIC CELLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
KINETICS;
LUNG NEOPLASMS;
LYMPHOCYTES;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
PEPTIDES;
RECOMBINANT PROTEINS;
T-LYMPHOCYTES, CYTOTOXIC;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 1942481506
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.12.4.493 Document Type: Article |
Times cited : (59)
|
References (0)
|